Apr 24
|
Eupraxia Pharmaceuticals to Present at Investor and Scientific Conferences in April and May
|
Feb 22
|
Craig-Hallum starts Eupraxia at Buy, sees ‘significant upside’ potential
|
Feb 18
|
Eupraxia Pharmaceuticals Announces CFO Succession
|
Oct 10
|
Eupraxia Pharmaceuticals to Present at United European Gastroenterology Week 2024
|
May 25
|
Eupraxia Pharmaceuticals Announces Last Patient Last Visit in Phase 2 Osteoarthritis Clinical Trial of EP-104IAR
|